{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:20:35Z","timestamp":1787811635493,"version":"build-2784847793"},"reference-count":33,"publisher":"The Endocrine Society","issue":"9","funder":[{"DOI":"10.13039\/100009898","name":"DHA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Age-related decline in serum testosterone is commonly cited as justification for testosterone replacement therapy, yet adiposity may represent a major modifiable determinant of circulating testosterone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To quantify the relative contributions of age, total adiposity, and visceral adiposity to circulating testosterone concentrations and prevalence of biochemical low testosterone in US adult men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional nationally representative analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>National Health and Nutrition Examination Survey (NHANES) 2011-2016.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Men aged 20 to 59 years with valid serum testosterone measurements (n = 4984).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Total testosterone (ng\/dL) and the prevalence of biochemical low testosterone (testosterone &amp;lt;300\u2005ng\/dL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Age explained only 2.5% of the variation in circulating testosterone (pseudo-R2 = 0.025). In contrast, dual-energy X-ray absorptiometry (DXA)-derived total percent body fat and visceral adipose tissue (VAT), and waist circumference each explained \u223c18% to 20% of testosterone variability. Waist circumference demonstrated slightly greater explanatory performance than DXA-derived VAT, indicating that simple anthropometric assessment captures much of the clinically relevant information provided by advanced imaging. Similar inverse associations were observed using multiple biochemical testosterone thresholds (300, 250, 200, and 150\u2005ng\/dL). Biochemically low testosterone was consistently associated with substantially greater adiposity across all age groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Measures of adiposity consistently demonstrated substantially stronger associations with circulating testosterone than chronological age alone. Waist circumference performed comparably to DXA-derived VAT, supporting its use as a clinically accessible marker of obesity-related testosterone suppression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag194","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:48:01Z","timestamp":1787140081000},"source":"Crossref","is-referenced-by-count":0,"title":["Adiposity, not chronological aging, is the dominant determinant of circulating testosterone in US adult men"],"prefix":"10.1210","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4980-8353","authenticated-orcid":false,"given":"Adam W","family":"Potter","sequence":"first","affiliation":[{"name":"U.S. Army Research Institute of Environmental Medicine , Natick, MA 01760-5007 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3134-8427","authenticated-orcid":false,"given":"Karl E","family":"Friedl","sequence":"additional","affiliation":[{"name":"U.S. Army Research Institute of Environmental Medicine , Natick, MA 01760-5007 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"5","key":"2026082702015850300_bvag194-B1","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1210\/jcem-73-5-1016","article-title":"Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study","volume":"73","author":"Gray","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026082702015850300_bvag194-B2","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1210\/jc.2007-1972","article-title":"Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study","volume":"93","author":"Wu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2026082702015850300_bvag194-B3","first-page":"668","volume-title":"Williams Textbook of Endocrinology","author":"Matsumoto","year":"2020","edition":"14th ed"},{"issue":"12","key":"2026082702015850300_bvag194-B4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrendo.2009.212","article-title":"Testosterone deficiency, insulin resistance and the metabolic syndrome","volume":"5","author":"Zitzmann","year":"2009","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2026082702015850300_bvag194-B5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13685538.2021.2023493","article-title":"Correlates of testosterone change as men age","volume":"25","author":"Kanabar","year":"2022","journal-title":"Aging Male"},{"issue":"1","key":"2026082702015850300_bvag194-B6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"issue":"3","key":"2026082702015850300_bvag194-B7","first-page":"1151","article-title":"Hypogonadotropic hypogonadism in men with obesity is associated with insulin resistance, inflammation, and increased aromatase activity","volume":"100","author":"Dhindsa","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026082702015850300_bvag194-B8","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1210\/jc.2004-2190","article-title":"Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men","volume":"90","author":"Pitteloud","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026082702015850300_bvag194-B9","first-page":"83","article-title":"Male obesity-related secondary hypogonadism\u2013pathophysiology, clinical implications and management","volume":"15","author":"Fernandez","year":"2019","journal-title":"Eur Endocrinol"},{"issue":"suppl 1","key":"2026082702015850300_bvag194-B10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/humrep\/12.suppl_1.21","article-title":"Hormonal control of regional fat distribution","volume":"12","author":"Bj\u00f6rntorp","year":"1997","journal-title":"Hum Reprod"},{"issue":"4","key":"2026082702015850300_bvag194-B11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1742-1241.2007.01317.x","article-title":"Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?","volume":"61","author":"Miner","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"1","key":"2026082702015850300_bvag194-B12","first-page":"3","article-title":"Androgen receptor structure, function and biology: from bench to bedside","volume":"37","author":"Davey","year":"2016","journal-title":"Clin Biochem Rev"},{"issue":"8","key":"2026082702015850300_bvag194-B13","doi-asserted-by":"crossref","first-page":"bvag160","DOI":"10.1210\/jendso\/bvag160","article-title":"Low testosterone is a phenotype of visceral adiposity","volume":"10","author":"Friedl","year":"2026","journal-title":"J Endocr Soc"},{"issue":"5","key":"2026082702015850300_bvag194-B14","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.ajcnut.2025.07.023","article-title":"Cross-sectional analysis of visceral adipose tissue associations with obesity-related disease","volume":"122","author":"Potter","year":"2025","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2026082702015850300_bvag194-B15","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-12-0455","article-title":"Testosterone: a metabolic hormone in health and disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J Endocrinol"},{"issue":"4","key":"2026082702015850300_bvag194-B16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/jc.2016-2935","article-title":"Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe","volume":"102","author":"Travison","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026082702015850300_bvag194-B17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.7326\/M23-0342","article-title":"Factors associated with circulating sex hormones in men: individual participant data meta-analyses","volume":"176","author":"Marriott","year":"2023","journal-title":"Ann Intern Med"},{"issue":"9","key":"2026082702015850300_bvag194-B18","doi-asserted-by":"crossref","first-page":"e3125","DOI":"10.1210\/clinem\/dgaf137","article-title":"Approach to the patient: low testosterone concentrations in men with obesity","volume":"110","author":"Muir","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026082702015850300_bvag194-B19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1373\/clinchem.2015.245969","article-title":"Serum total testosterone concentrations in the US household population from the NHANES 2011\u20132012 study population","volume":"61","author":"Vesper","year":"2015","journal-title":"Clin Chem"},{"issue":"4","key":"2026082702015850300_bvag194-B20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jocd.2019.03.005","article-title":"Precision of the hologic DXA in the assessment of visceral adipose tissue","volume":"23","author":"Goldberg","year":"2020","journal-title":"J Clin Densitom"},{"issue":"1","key":"2026082702015850300_bvag194-B21","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.1002\/oby.20140","article-title":"Precision of a new tool to measure visceral adipose tissue (VAT) using dual-energy X-ray absorptiometry (DXA)","volume":"21","author":"Rothney","year":"2013","journal-title":"Obesity"},{"key":"2026082702015850300_bvag194-B22","unstructured":"Potter AW, Friedl KE. Supplemental material for: \u201cAdiposity, not chronological aging, is the dominant determinant of circulating testosterone in U.S. adult men\u201d. Mendeley Data. doi: 10.17632\/tbwrzp4s5c.1."},{"issue":"5","key":"2026082702015850300_bvag194-B23","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1152\/jappl.2000.88.5.1820","article-title":"Endocrine markers of semistarvation in healthy lean men in a multistressor environment","volume":"88","author":"Friedl","year":"2000","journal-title":"J Appl Physiol"},{"issue":"21","key":"2026082702015850300_bvag194-B24","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1001\/jama.2011.710","article-title":"Effect of 1 week of sleep restriction on testosterone levels in young healthy men","volume":"305","author":"Leproult","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"2026082702015850300_bvag194-B25","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1210\/clinem\/dgae341","article-title":"Defining overweight and obesity by percent body fat instead of body mass index","volume":"110","author":"Potter","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026082702015850300_bvag194-B26","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/jamainternmed.2022.4928","article-title":"Guideline-discordant care among direct-to-consumer testosterone therapy platforms","volume":"182","author":"Dubin","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"7","key":"2026082702015850300_bvag194-B27","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1210\/jc.2018-01882","article-title":"Diagnosis and management of anabolic androgenic steroid use","volume":"104","author":"Anawalt","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026082702015850300_bvag194-B28","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026082702015850300_bvag194-B29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EC-18-0514","article-title":"Effects of liraglutide on obesity-associated functional hypogonadism in men","volume":"8","author":"Jensterle","year":"2019","journal-title":"Endocr Connect"},{"issue":"8","key":"2026082702015850300_bvag194-B30","doi-asserted-by":"crossref","first-page":"e0289616","DOI":"10.1371\/journal.pone.0289616","article-title":"The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population with or without diabetes and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"18","author":"Liao","year":"2023","journal-title":"PLoS One"},{"issue":"4-6","key":"2026082702015850300_bvag194-B31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0960-0760(91)90283-B","article-title":"Comparison of the effects of high dose testosterone and 19-nortestosterone to a replacement dose of testosterone on strength and body composition in normal men","volume":"40","author":"Friedl","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"2026082702015850300_bvag194-B32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2017-00234","article-title":"Lessons from the testosterone trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr Rev"},{"issue":"1","key":"2026082702015850300_bvag194-B33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mayocp.2017.11.006","article-title":"Testosterone and cardiovascular health","volume":"93","author":"Elagizi","year":"2018","journal-title":"Mayo Clin Proc"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag194\/70721092\/bvag194.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/9\/bvag194\/70721092\/bvag194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/9\/bvag194\/70721092\/bvag194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:02:05Z","timestamp":1787810525000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag194\/8766941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag194","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,1]]},"article-number":"bvag194"}}